Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate for local anesthesia-assisted sedation vs propofol (Phase II)
ChiCTR2100054956Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of remimazolam in Procedural anxiety and pain (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Percentage of time maintaining target sedation (MOAA/S 1-4) during dosing. Started May 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
Procedural anxietypain
Beyond the preview
Go deeper on ChiCTR2100054956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054956.